Last reviewed · How we verify

NCT03501186

Effects of Backward Gait on Sand on Improving the Gait Parameters of Patients With Chronic Stroke.

Status unknown NA Last updated 1 June 2018
What this trial tests

NA trial testing Backward walking on sand in Chronic Stroke in 20 participants. Status unknown.

Timeline
12 January 2017
Primary endpoint
20 June 2018
21 July 2018

Quick facts

Lead sponsorMajmaah University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment20
Start date12 January 2017
Primary completion20 June 2018
Estimated completion21 July 2018
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Majmaah University

Who can join

Adults 45 to 80, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gait training in stroke is a complex process of motor learning although restoring patients ability to walk would not prepare the individual with the challenges faced in the real environment. The aim is not simply walking in controlled environment, but to achieve dynamic walking. Dynamic walking is the ability of an individual to adjust to the changing surfaces and terrains. thereby returning to achieve active participation in the community. Hence, recovery of walking ability is the primary goal when planning treatment for patients with stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Stroke

Currently open trials in the same condition.

Other Majmaah University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03501186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing